Product: Ethyl-5-metoxy-1H-indole-2-carboxylate
Catalog Number: 5648
CAS Number: 4792-58-9
Synonyms: 5-Methylindole-2-carboxylic acid ethyl ester;
2-Ethoxycarbonyl-5-methoxyindole;
2-Carbethoxy-5-methoxyindole;
Ethyl 5-methoxyindole-2-carboxylate
Pricing:
Inquire  
Formula: C12H13NO3
Molecular Weight: 219.24
Structure: Ethyl-5-metoxy-1H-indole-2-carboxylate
Appearance: Crystalline
Category: Unlabeled Reference Standards
Stability: Stable under recommended storage conditions.
Storage:

Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature: -20°C

Transportation:

Non-hazardous for transport

Literature References:

Lee, J. H.; et al., Synthesis of a new fluorescent small molecule probe and its use for in vivo lipid imaging Chem. Commun. (Camb.) 47, 7500, (2011); Dolusic, E.; et al., Indol-2-yl ethanones as novel indoleamine 2,3-dioxygenase (IDO) inhibitors Bioorg. Med. Chem. 19, 3029, (2011); Parwati, C. V.; et al., Synthesis and antimicrobial activity of triazinoindoles Int. Res. J. Pharm. 2, 175, (2011); Al-Qirim, T.; et al., Pharmacological evaluation of novel indole-2-carboxamides as potent lipid-lowering agents in Triton-WR-1339-induced hyperlipidemic rats Z. Naturforsch. C 64, 619, (2009); Romagnoli, R.; et al., Discovery of 8-methoxypyrazino[1,2-a]indole as a new potent antiproliferative agent against human leukemia K562 cells. a structure-activity relationship study Lett. Drug Des. Discov. 6, 298, (2009); Liou, J.-P.; et al., Discovery of 4-Amino and 4-Hydroxy-1-aroylindoles as Potent Tubulin Polymerization Inhibitors J. Med. Chem. 51, 4351, (2008); Campbell, J. A.; et al., A new synthesis of 3-arylthioindoles as selective COX-2 inhibitors using PIFA Tetrahedron Lett. 45, 4073, (2004); Perzyna, A.; et al., New benzo[5,6]pyrrolizino[1,2-b]quinolines as cytotoxic agents Bioorg. Med. Chem. Lett. 14, 2363, (2004)

MSDS:
Applications:

Reactant for preparation of:
• Ligands with binding specificity towards the GABA receptor
• Sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors for the management of hyperglycemia in diabetes
• Anticancer agents
• Integrase strand-transfer inhibitors (INSTIs)
• Inhibitor of Proliferation of Colon Cancer Cells
• Isomeridianin G as GSK-3? inhibitors
• HIV-1 integrase inhibitors
• Inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)